Mesoblast (MESO) Return on Sales [ROS] (2015 - 2023)
Mesoblast (MESO) reported Return on Sales [ROS] of 214.92% for the year ended Jun 30, 2026, down 286.21 percentage points from 501.13% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Return on Sales [ROS] (2015 - 2023) Analysis & Trends
Dating back to the year ended Jun 30, 2015, Mesoblast's Return on Sales [ROS] record includes 12 years.
- Return on Sales [ROS] has a five-year change of +1699.23 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 ranks as the lowest annual Return on Sales [ROS] since the year ended Jun 30, 2022.
- According to Business Quant data, Return on Sales [ROS] came in at 501.13% in the year ended Jun 30, 2025 (-695.04 pp), 1196.17% in the year ended Jun 30, 2024 (+25.70 pp), 1170.47% in the year ended Jun 30, 2023 (+2236.71 pp) and -1066.24% in the year ended Jun 30, 2022 (+418.07 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Mesoblast | 1.82 Bn | 1.39 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -2,699.91% |
| Mar 31, 2023 | -1,218.67% |
| Dec 31, 2022 | -1,440.72% |
| Sep 30, 2022 | -1,426.21% |
| Jun 30, 2022 | -2,326.03% |
| Mar 31, 2022 | -1,255.99% |
| Dec 31, 2021 | -1,317.88% |
| Sep 30, 2021 | -733.64% |
| Jun 30, 2021 | -1,299.85% |
| Mar 31, 2021 | -1,558.22% |
| Dec 31, 2020 | -1,190.54% |
| Sep 30, 2020 | -2,159.16% |
| Jun 30, 2020 | -5,729.24% |
| Mar 31, 2020 | -169.10% |
| Dec 31, 2019 | -1,332.50% |
| Sep 30, 2019 | -63.78% |
| Jun 30, 2019 | -1,389.17% |
| Mar 31, 2019 | -2,397.36% |
| Dec 31, 2018 | -1,601.87% |
| Sep 30, 2018 | -196.46% |
API Access
Mesoblast Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();